When Methods Matter: An Umbrella Review of Lorundrostat and the Impact of Analytical Decisions on Reported Blood Pressure and Safety Outcomes.
Zeyad Elariny, Omar Salem, Mohamad Ashraf Salaheldin et al.
✦ AI-curated · Sources linked
In 30 seconds
This umbrella review evaluated the effects of lorundrostat on blood pressure and hyperkalemia risk in adults with uncontrolled hypertension, synthesizing data from ten systematic reviews and meta-analyses. The study found that office systolic blood pressure reductions varied from -7.35 to -13.55 mmHg, highlighting significant methodological variability in reported outcomes.
Key findings
- Office systolic blood pressure reductions ranged from -7.35 to -13.55 mmHg.
- 24-hour ambulatory systolic blood pressure reductions varied from -5.65 to -7.45 mmHg.
- Lorundrostat was associated with a hyperkalemia risk ratio of 3.19-11.63.
Why it matters
Understanding the variability in blood pressure outcomes and safety profiles of lorundrostat is crucial for clinicians managing patients with uncontrolled hypertension. This review underscores the need for standardized methodologies in clinical research to ensure reliable treatment assessments.
What to keep in mind
Methodological quality of included reviews was predominantly low to critically low, and there was limited long-term data.